Hipolin Ltd

Hipolin Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 13 July 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 30 July 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook.

Hipolin Ltd, a micro-cap player in the FMCG sector, has seen its investment rating upgraded from Strong Sell to Sell as of 13 July 2026. This change reflects a nuanced shift in the company’s technical outlook amid persistently weak financial fundamentals and valuation concerns. Investors are advised to weigh the improved technical signals against the company’s flat financial performance and deteriorating promoter confidence.

Hipolin Ltd, a micro-cap player in the FMCG sector, has been downgraded from a Sell to a Strong Sell rating by MarketsMOJO as of 8 July 2026. This revision reflects deteriorating technical indicators, stagnant financial performance, and weakening long-term fundamentals, signalling heightened risk for investors despite a modest year-to-date stock return of 20.8%.

Hipolin Ltd, a micro-cap player in the FMCG sector, has seen its investment rating upgraded from Strong Sell to Sell as of 30 June 2026. This change reflects a nuanced shift in the company’s technical outlook despite persistent fundamental challenges, signalling cautious optimism tempered by ongoing risks.

Hipolin Ltd, a micro-cap player in the FMCG sector, has seen its investment rating downgraded from Sell to Strong Sell as of 25 June 2026. This adjustment reflects deteriorating technical indicators, stagnant financial performance, and weakening valuation metrics, signalling heightened risk for investors amid a challenging market environment.

Hipolin Ltd., a micro-cap FMCG company with a market capitalisation of ₹28.00 crores, reported marginal profitability in Q4 FY26 (Mar'26), posting a net profit of ₹0.01 crores compared to a loss of ₹2.36 crores in the same quarter last year. However, this technical recovery masks significant underlying concerns, as revenue declined 10.45% year-on-year to ₹3.94 crores, and the company continues to struggle with negative return on equity of -49.53%. The stock has declined 1.99% following the results announcement, trading at ₹89.14 and reflecting investor scepticism about the sustainability of this fragile turnaround.

Hipolin Ltd, a micro-cap player in the FMCG sector, has seen its investment rating upgraded from Strong Sell to Sell as of 26 May 2026. This change is primarily driven by a shift in technical indicators, even as the company continues to grapple with weak financial fundamentals and valuation concerns. Investors should weigh the improved technical outlook against persistent operational challenges before making decisions.

Hipolin Ltd, a micro-cap player in the FMCG sector, has seen its investment rating downgraded from Sell to Strong Sell as of 11 May 2026, reflecting deteriorating fundamentals, subdued financial trends, and a shift in technical indicators. The company’s current Mojo Score stands at 23.0, underscoring significant concerns for investors amid a challenging market environment.

Hipolin Ltd, a micro-cap player in the FMCG sector, has seen its investment rating upgraded from Strong Sell to Sell as of 5 May 2026, driven primarily by a shift in technical indicators despite persistent fundamental challenges. This nuanced change reflects a mild bullishness in market sentiment, although the company’s financial health and valuation metrics remain under pressure.

Hipolin Ltd’s share price declined to a fresh 52-week low of Rs.44.83 on 24 March 2026, marking a significant downturn for the micro-cap FMCG company as it continues to underperform both its sector and the broader market indices.

For the fifth straight session, Hipolin Ltd closed lower, breaching its 52-week low at Rs 47.26 on 23 Mar 2026, marking a cumulative decline of 17.06% over this period amid a broader market downturn.

Hipolin Ltd, a player in the FMCG sector, has witnessed its stock price decline to a fresh 52-week low of Rs.47.58 as of 9 March 2026, reflecting ongoing pressures on the company’s financial performance and market standing.

Hipolin Ltd, a player in the FMCG sector, witnessed its stock price decline to a fresh 52-week low of Rs.50 today, marking a significant milestone in its ongoing downward trajectory. The stock has now recorded a consecutive six-day fall, accumulating a loss of 19.71% over this period, reflecting persistent pressures on the company’s market valuation.

Hipolin Ltd., a micro-cap FMCG company with a market capitalisation of ₹20.00 crores, reported marginal profitability in Q3 FY26 (October-December 2025), posting net profit of ₹0.01 crores—a stark reversal from the ₹0.57 crore loss in the year-ago quarter. However, this improvement masks deeper structural challenges as the company continues to grapple with collapsing revenues, negative operating margins, and persistent financial distress that has plagued operations for the past year.

Hipolin Ltd’s shares declined to a fresh 52-week low of Rs.51.5 on 29 Jan 2026, marking a significant drop amid sustained negative momentum. The stock has underperformed its sector and broader market indices, reflecting ongoing concerns about the company’s financial health and market position.

Hipolin Ltd is rated Strong Sell by MarketsMOJO. This rating was last updated on 19 Sep 2025, reflecting a reassessment of the stock’s outlook. However, all fundamentals, returns, and financial metrics discussed here are current as of 26 December 2025, providing investors with the latest comprehensive view of the company’s position.